Cohort of Patients With Pelvic Gynecological Cancer: Constitution of a Collection of Biological Samples With Radioclinical Characterization
Centre Hospitalier Intercommunal Creteil
500 participants
May 1, 2017
OBSERVATIONAL
Conditions
Summary
The management of pelvic gynecological cancers (PGC) is based on the determination of extension to guide treatments. The biology of the CGP is constantly evolving and personalized medicine adapted to this biology is currently in full development. For example, sequencing ovarian tumors can select patients who can benefit from anti-PARP therapy. There is therefore a need for patients to have biological samples of their tumor. Various studies on ovarian, endometrial and cervical cancer have sought to identify the factors predictive of recurrence of these cancers. The results obtained are very promising. This study will permit to collect biological samples and detailed clinical data that would allow to test hypotheses and develop a personalized medicine based on clinical and biological characteristics of patients.
Eligibility
Inclusion Criteria5
- Diagnosis of pelvic gynecological cancer posed on initial histological analysis or during recurrence;
- Or diagnosis of endometriosis on histology or imaging
- Age ≥ 18 years;
- Affiliation to the general social security scheme;
- Consent signed.
Exclusion Criteria2
- Refusal of the patient;
- Non-affiliation to the general social security scheme.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Recovery of surgical waste during surgery planned in the current care and clinical data collection
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT03622983